Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma

14 Feb 2014

Abstract excerpt

INTRODUCTION: We assessed the profile and frequency of malignancy subtypes in a large single-centre UK cohort for patients with scleroderma (systemic sclerosis; SSc). We evaluated the cancer risk among SSc patients with different antibody reactivities and explored the temporal association of cancer with the duration between SSc onset and cancer diagnosis. METHODS: We conducted a retrospective study of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Multiple Sclerosis Research Studies
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24524733
DOI: 10.1186/ar4486

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of anti-RNA polymerase III autoantibodies and cancer in sclerodermaPMID 24524733Read ↗

Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer.Semantic proximity Read ↗

Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodiesSemantic proximity Read ↗

Genomic instability in early systemic sclerosisSemantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.Semantic proximity Read ↗

An update on autoantibodies in scleroderma.Semantic proximity Read ↗

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.Semantic proximity Read ↗

Disease-related autoantibody profile in patients with systemic sclerosisSemantic proximity Read ↗

Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey.Semantic proximity Read ↗

Association of differentially expressed genes and autoantibody type in patients with systemic sclerosisSemantic proximity Read ↗

The Genomic Landscape of NSCLC in Systemic Sclerosis Reveals Frequent TP53 Mutations and a Paucity of Actionable Oncogenes.Semantic proximity Read ↗

Association of the autoimmune disease scleroderma with an immunologic response to cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.